Lenvatinib plus Pembrolizumab for Advanced Endometrial Cancer

for the Study 309–KEYNOTE-775 Investigators

Research output: Contribution to journalArticlepeer-review

100 Scopus citations

Fingerprint

Dive into the research topics of 'Lenvatinib plus Pembrolizumab for Advanced Endometrial Cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences